openPR Logo
Press release

Clinical Trial Management System Market size to surpass around USD 5.7 billion by 2032 | Advarra, Inc. (US), Clario (US), Dassault Systèmes S.E. (Medidata)

09-15-2023 05:31 AM CET | Health & Medicine

Press release from: Global Insight Services

The global Clinical Trials Management System Market was valued at 1.4 billion in 2022 and it is anticipated to grow up to USD 5.7 billion by 2032, at a CAGR of 15.1% during the forecast period.

Get Access to A Free Sample Copy of Our Latest Report - https://www.globalinsightservices.com/request-sample/GIS20232

A clinical trial management system (CTMS) is a software system used by biotechnology and pharmaceutical industries to manage clinical trials. The system aims to manage and maintain tracking of patient data. Clinical trial management systems incorporate different components consisting of software, hardware, and services. Clinical trial management system provides data to business intelligence system, which acts as access centralized data, thus reducing the number of delayed trials.

Market Trends and Drivers

Growth of the global clinical trial management market is majorly driven by increase in industry academic collaborations, rise in number of clinical trials, growth in technology in the healthcare sector, and increase in government support for research trials. In addition, growth in number of clinical trial management system (CTMS) is attributed to factors such as high prevalence of chronic diseases. Furthermore, products of clinical trial management system are efficient, easy to use, provide effective patient safety and regulatory compliances, and enhance financial management. For instance, in December 2020, Environmental Response Team (ERT), a global company specializing in clinical services, announced the launch of data insight to enhance the study effectiveness and efficiency.

Report Overview- https://www.globalinsightservices.com/reports/clinical-trial-management-system-market

 Moreover, in January 2020, Veeva, a cloud computing company, announced the launch of veeva vault payment software, which is an application used for veeva vault CTMS. Growth in number of clinical trials and increase in number of key players to develop advanced clinical trial management system (CTMS) solution drive the market growth.

Market Restraints and Challenges

One of the key factors restraining the growth of the market is the lack of standardization in the clinical trial process. This lack of standardization can lead to errors and delays in the clinical trial process. The another key factors restraining is the lack of skilled personnel. This lack of skilled personnel can lead to delays in the clinical trial process. Moreover, the cost of clinical trials can be a major challenge in the CTMS market. The cost of clinical trials can be a barrier to entry for many companies.

Major Players in the Global Clinical Trials Management System Market

Market players are focusing on strategic collaborations to enhance their product offerings. Some prominent participants in the global Advarra, Inc. (US), Clario (US), Dassault Systèmes S.E. (Medidata) (France), DATATRAK International, Inc. (US), DSG, Inc. (US), Elligo Health Research (US), MasterControl Solutions, Inc. (US), Oracle Corporation (US), Parexel International Corporation (US), and Veeva Systems Inc. (US), among others.

COVID-19 Impact:

The COVID-19 pandemic significantly impacted the Clinical Trials Management System (CTMS) market. This included disruption in clinical trials, hurdles in patient recruitment, and canceled or delayed studies. As per a study published in the U.S. National Library of Medicine in 2020, the pandemic resulted in delayed subject enrollment and operational gaps in most ongoing clinical trials. This in turn negatively impacted trial programs and data integrity. Globally, most sites conducting clinical trials other than COVID-19 were found to experience delays in timelines. In some cases, clinical trials were found to reach a complete halt of operations, thus impacting clinical research outcomes. In March 2020, the U.S. FDA published a guidance document on the Conduct of Clinical Trials of Medical Products during the pandemic. Similar guidelines supported the recovery of the clinical trial operations, and the number is anticipated to increase over time

Get A Customized Scope to Match Your Need Ask an Expert - https://www.globalinsightservices.com/request-customization/GIS20232

However, the negative impact was gradually reduced by several strategic measures taken by governments, regulatory bodies, and market stakeholders to ensure the continuity of R&D. The need to develop vaccines for the coronavirus also boosted the adoption of decentralized clinical trials. According to the COVID-NMA (an initiative by WHO), as of February 2022, over 750 studies were registered for COVID-19 vaccine development. Also, the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) released guidelines to urgently advance COVID-19 vaccine equity. The IFPMA reported that 5 of its members had received approval for COVID-19 vaccines while 14 more were under clinical development This is expected to increase the adoption of CTM systems.

Market Segments

By Component

Software
Services

By Delivery Mode

Web-based (On-demand)
Licensed Enterprise (On-premises)
Cloud-based (SaaS)

By Deployment Type

Enterprise-wide CTMS
On-Site CTMS

By End User

Large Pharma-biotech Companies
CROs
Medical Device Manufacturers
Small & Mid-sized Pharma-biotech Companies
Others

Buy Now - https://www.globalinsightservices.com/checkout/single_user/GIS20232

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology

New Report Published by Global Insight Services -https://www.globalinsightservices.com/reports/hydrogen-projects-database/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Clinical Trial Management System Market size to surpass around USD 5.7 billion by 2032 | Advarra, Inc. (US), Clario (US), Dassault Systèmes S.E. (Medidata) here

News-ID: 3209006 • Views:

More Releases from Global Insight Services

Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing at 17.5% CAGR | Overall Study Report
Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing …
The Immuno Oncology Drugs Market is rapidly emerging as a transformative segment in the global healthcare industry. These drugs harness the body's immune system to identify and attack cancer cells, offering innovative treatment alternatives to traditional chemotherapy and radiation therapies. Immuno-oncology therapies include monoclonal antibodies, checkpoint inhibitors, cancer vaccines, and cell-based therapies such as CAR-T cells. The growth of this market is primarily driven by advancements in biotechnology, an improved
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Overall Study Report
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Ove …
The GLP 1 Market is experiencing unprecedented growth, fueled by the rising prevalence of type 2 diabetes and obesity globally. GLP-1, or glucagon-like peptide-1 receptor agonists, represents a groundbreaking therapeutic class that improves insulin secretion, reduces glucagon production, and slows gastric emptying. These mechanisms not only enhance glycemic control but also support weight management, making GLP-1 therapies a preferred choice among healthcare providers and patients alike. Over the years, the
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAGR | Key Players: EasyMile, Navya, Aurrigo
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAG …
Market Overview Autonomous Bus Market is revolutionizing the future of urban mobility through advanced automation technologies. Valued at $2.1 billion in 2024, the market is projected to reach $11.6 billion by 2034, expanding at a strong CAGR of 18.8%. This market focuses on the development and deployment of self-driving buses equipped with cutting-edge sensors, artificial intelligence, and vehicle-to-everything (V2X) communication systems. These buses are designed to improve road safety, enhance passenger
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | Key Players: Apollo Tyres, Nokian Tyres, Hankook Tire
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | …
Market Overview Automotive Tire Market is experiencing remarkable growth as the industry embraces innovation, sustainability, and digital transformation. Valued at $406 billion in 2024, the market is projected to soar to $976.7 billion by 2034, reflecting a CAGR of 9.2%. This expansion is primarily driven by the surge in global vehicle production, growing consumer preference for durable and high-performance tires, and the increasing adoption of smart tire technologies. The Automotive Tire

All 5 Releases


More Releases for CTM

Clinical Trial Management (CTM) Market 2022 | Detailed Report
The Clinical Trial Management (CTM) research report combines vital data incorporating the competitive landscape, global, regional, and country-specific market size, market growth analysis, market share, recent developments, and market growth in segmentation. Furthermore, the Clinical Trial Management (CTM) research report offers information and thoughtful facts like share, revenue, historical data, and global market share. It also highlights vital aspects like opportunities, driving, product scope, market overview, and driving force. Download FREE
Corporate Travel Management (CTM) Software Market Outlook 2022: Big Things are H …
Global Corporate Travel Management (CTM) Software Market Size, Status and Forecast 2022-2028 is latest research study released by HTF MI evaluating the market risk side analysis, highlighting opportunities and leveraged with strategic and tactical decision-making support (2022-2028). The report provides information on market trends and development, growth drivers, technologies, and the changing investment structure of the Global Corporate Travel Management (CTM) Software Market. Some of the key players profiled in
Clinical Trial Management (CTM) Market Overview, Scope and Advancement Outlook T …
The Global Clinical Trial Management (CTM) Market is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data that enhances the understanding, scope, and application of this report. The global Clinical
Clinical Trial Management (CTM) Market Expected to face $1,371 Million by 2023
According to a new report published by Allied Market Research, titled, "Clinical Trial Management Market by Delivery Mode, Product, Component, End Users, and Region: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global clinical trial management market accounted for $570 million in 2016, and is estimated to reach $1,371 million by 2023, registering a CAGR of 13.4% from 2017 to 2023. North America is the highest contributor in the clinical
Clinical Trial Management (CTM) Market Report 2018: Segmentation by Delivery Mod …
Global Clinical Trial Management (CTM) market research report provides company profile for Oracle, Medidata Solutions, Parexel, BioClinica, Inc., Bio-Optronics, IBM, MedNet Solutions, Veeva Systems, Forte Research Systems and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to
Clinical Trial Management Market (CTM) to Hit $1,371 Million by 2023
According to a new report published by Allied Market Research, titled, Clinical Trial Management Market by Delivery Mode, Product, Component, End Users, and Region: Global Opportunity Analysis and Industry Forecast, 2017-2023, the global clinical trial management market accounted for $570 million in 2016, and is estimated to reach $1,371 million by 2023, registering a CAGR of 13.4% from 2017 to 2023. North America is the highest contributor in the clinical